New Ray Medicine Proposes New Bye-Laws to Support Uncertificated Share Transfers

Bulletin Express

Apr 27

New Ray Medicine International Holding Limited announced plans to adopt a third amended and restated set of Bye-Laws (the “New Bye-Laws”), replacing the current second amended and restated version.

The Board’s key objectives are: 1. Alignment with Hong Kong Stock Exchange requirements ahead of the Uncertificated Securities Market (USM) launch, enabling shareholders to hold and transfer shares in uncertificated form. 2. Miscellaneous housekeeping updates to reflect the latest Listing Rules.

Implementation timetable: • A special resolution will be tabled at the forthcoming annual general meeting (AGM). • The New Bye-Laws will become effective immediately after the AGM, subject to shareholder approval.

Procedural details: • A circular containing full text of the proposed amendments, AGM notice and proxy form will be issued in due course. • The Board confirmed that, after reasonable enquiry, no shareholder is required to abstain from voting on the resolution.

Board composition (as of 27 April 2026): • Executive Directors – Wang Qiuqin (Chairman), Chu Xueping, Zhou Wan. • Independent Non-Executive Directors – Leung Chi Kin, Li Sin Ming, Ivy, Sy Lai Yin, Sunny.

The proposed governance changes position New Ray Medicine to comply seamlessly with upcoming market infrastructure reforms while updating its corporate constitution to current regulatory standards.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1118721692"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118721692\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118721692?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 20:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118721692","market":"us","top_or_hot":-1,"title":"New Ray Medicine Proposes New Bye-Laws to Support Uncertificated Share Transfers","media":"Bulletin Express","content":"<p>New Ray Medicine International Holding Limited announced plans to adopt a third amended and restated set of Bye-Laws (the “New Bye-Laws”), replacing the current second amended and restated version.</p>\n<p>The Board’s key objectives are:  \n1. Alignment with Hong Kong Stock Exchange requirements ahead of the Uncertificated Securities Market (USM) launch, enabling shareholders to hold and transfer shares in uncertificated form.  \n2. Miscellaneous housekeeping updates to reflect the latest Listing Rules.</p>\n<p>Implementation timetable:  \n• A special resolution will be tabled at the forthcoming annual general meeting (AGM).  \n• The New Bye-Laws will become effective immediately after the AGM, subject to shareholder approval.</p>\n<p>Procedural details:  \n• A circular containing full text of the proposed amendments, AGM notice and proxy form will be issued in due course.  \n• The Board confirmed that, after reasonable enquiry, no shareholder is required to abstain from voting on the resolution.</p>\n<p>Board composition (as of 27 April 2026):  \n• Executive Directors – Wang Qiuqin (Chairman), Chu Xueping, Zhou Wan.  \n• Independent Non-Executive Directors – Leung Chi Kin, Li Sin Ming, Ivy, Sy Lai Yin, Sunny.</p>\n<p>The proposed governance changes position New Ray Medicine to comply seamlessly with upcoming market infrastructure reforms while updating its corporate constitution to current regulatory standards.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Ray Medicine Proposes New Bye-Laws to Support Uncertificated Share Transfers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Ray Medicine Proposes New Bye-Laws to Support Uncertificated Share Transfers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-27 20:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>New Ray Medicine International Holding Limited announced plans to adopt a third amended and restated set of Bye-Laws (the “New Bye-Laws”), replacing the current second amended and restated version.</p>\n<p>The Board’s key objectives are:  \n1. Alignment with Hong Kong Stock Exchange requirements ahead of the Uncertificated Securities Market (USM) launch, enabling shareholders to hold and transfer shares in uncertificated form.  \n2. Miscellaneous housekeeping updates to reflect the latest Listing Rules.</p>\n<p>Implementation timetable:  \n• A special resolution will be tabled at the forthcoming annual general meeting (AGM).  \n• The New Bye-Laws will become effective immediately after the AGM, subject to shareholder approval.</p>\n<p>Procedural details:  \n• A circular containing full text of the proposed amendments, AGM notice and proxy form will be issued in due course.  \n• The Board confirmed that, after reasonable enquiry, no shareholder is required to abstain from voting on the resolution.</p>\n<p>Board composition (as of 27 April 2026):  \n• Executive Directors – Wang Qiuqin (Chairman), Chu Xueping, Zhou Wan.  \n• Independent Non-Executive Directors – Leung Chi Kin, Li Sin Ming, Ivy, Sy Lai Yin, Sunny.</p>\n<p>The proposed governance changes position New Ray Medicine to comply seamlessly with upcoming market infrastructure reforms while updating its corporate constitution to current regulatory standards.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06108","symbol_name":"新锐医药","start_time":0,"source_url":"","article_id":"1118721692","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118721692","pubTimestamp":1777293943,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"New Ray Medicine International Holding Limited announced plans to adopt a third amended and restated set of Bye-Laws (the “New Bye-Laws”), replacing the current second amended and restated version....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06108":"新锐医药"},"translate_title":"新射线医学提出新公司细则支持非凭证股份转让","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06108":1},"content_text":"New Ray Medicine International Holding Limited announced plans to adopt a third amended and restated set of Bye-Laws (the “New Bye-Laws”), replacing the current second amended and restated version.\nThe Board’s key objectives are:  \n1. Alignment with Hong Kong Stock Exchange requirements ahead of the Uncertificated Securities Market (USM) launch, enabling shareholders to hold and transfer shares in uncertificated form.  \n2. Miscellaneous housekeeping updates to reflect the latest Listing Rules.\nImplementation timetable:  \n• A special resolution will be tabled at the forthcoming annual general meeting (AGM).  \n• The New Bye-Laws will become effective immediately after the AGM, subject to shareholder approval.\nProcedural details:  \n• A circular containing full text of the proposed amendments, AGM notice and proxy form will be issued in due course.  \n• The Board confirmed that, after reasonable enquiry, no shareholder is required to abstain from voting on the resolution.\nBoard composition (as of 27 April 2026):  \n• Executive Directors – Wang Qiuqin (Chairman), Chu Xueping, Zhou Wan.  \n• Independent Non-Executive Directors – Leung Chi Kin, Li Sin Ming, Ivy, Sy Lai Yin, Sunny.\nThe proposed governance changes position New Ray Medicine to comply seamlessly with upcoming market infrastructure reforms while updating its corporate constitution to current regulatory standards.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}